PlainRecalls
FDA Drug Moderate Class II Ongoing

LOSARTAN POTASSIUM TABLETS, USP, 25 mg, 90-count bottle (NDC: 13668-113-90), Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana Inda

Reported: February 27, 2019 Initiated: December 20, 2018 #D-0503-2019

Product Description

LOSARTAN POTASSIUM TABLETS, USP, 25 mg, 90-count bottle (NDC: 13668-113-90), Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana Inda

Reason for Recall

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Details

Recalling Firm
Torrent Pharma Inc.
Units Affected
43,416 bottles
Distribution
Nationwide USA and Puerto Rico
Location
Kalamazoo, MI

Frequently Asked Questions

What product was recalled?
LOSARTAN POTASSIUM TABLETS, USP, 25 mg, 90-count bottle (NDC: 13668-113-90), Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana Inda. Recalled by Torrent Pharma Inc.. Units affected: 43,416 bottles.
Why was this product recalled?
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 27, 2019. Severity: Moderate. Recall number: D-0503-2019.